| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.880 | 8.517 | 8.892 | 10.142 | 9.294 | 7.537 | 9.066 | 7.596 | 7.779 | 6.372 |
| Total Income - EUR | 9.881 | 8.517 | 8.892 | 10.142 | 9.295 | 7.537 | 9.066 | 7.597 | 7.780 | 6.373 |
| Total Expenses - EUR | 7.425 | 7.569 | 7.531 | 8.731 | 10.117 | 9.751 | 7.464 | 3.131 | 3.798 | 4.242 |
| Gross Profit/Loss - EUR | 2.455 | 948 | 1.361 | 1.411 | -823 | -2.214 | 1.602 | 4.467 | 3.982 | 2.131 |
| Net Profit/Loss - EUR | 2.159 | 778 | 1.272 | 1.309 | -916 | -2.289 | 1.380 | 4.239 | 3.345 | 1.790 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Medigen Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 10.054 | 10.642 | 7.981 | 9.406 | 8.322 | 5.875 | 2.554 | 4.597 | 4.350 | 5.290 |
| Inventories | 7 | 8 | 7 | 7 | 361 | 0 | 325 | 340 | 558 | 541 |
| Receivables | 803 | 436 | 44 | 86 | 0 | 208 | 642 | 41 | 1.830 | 27 |
| Cash | 9.244 | 10.198 | 7.930 | 9.313 | 7.961 | 5.667 | 1.587 | 4.217 | 1.963 | 4.722 |
| Shareholders Funds | 9.401 | 6.234 | 7.401 | 8.574 | 7.493 | 5.061 | 2.287 | 4.302 | 3.398 | 5.169 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 653 | 4.408 | 580 | 832 | 829 | 814 | 268 | 295 | 952 | 122 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Medigen Srl